Jun Yan
Directeur/Membre du Conseil chez JIANGSU SHENTONG VALVE CO., LTD.
Profil
Jun Yan currently works at Jiangsu Shentong Valve Co., Ltd., as Independent Director from 2019, Shanghai Allist Pharmaceuticals Co., Ltd., as Independent Director from 2019, and Shanghai Haihe Biopharma Co., Ltd., as Independent Director from 2020.
Mr. Yan also formerly worked at Wenfeng Great World Chain Development Corp., as Independent Director.
Mr. Yan received his undergraduate degree from Fudan University.
Postes actifs de Jun Yan
Sociétés | Poste | Début |
---|---|---|
JIANGSU SHENTONG VALVE CO., LTD. | Directeur/Membre du Conseil | 25/07/2019 |
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Directeur/Membre du Conseil | 28/11/2019 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 08/09/2020 |
Anciens postes connus de Jun Yan
Sociétés | Poste | Fin |
---|---|---|
WENFENG GREAT WORLD CHAIN DEVELOPMENT CORPORATION | Directeur/Membre du Conseil | - |
Formation de Jun Yan
Fudan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
WENFENG GREAT WORLD CHAIN DEVELOPMENT CORPORATION | Retail Trade |
JIANGSU SHENTONG VALVE CO., LTD. | Producer Manufacturing |
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |